ATTO - Latest News
Attovia Therapeutics, Inc. (ATTO), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $890.7M. Beta to the broader market is 0.00.
The article list below shows the most recent ATTO headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent ATTO Headlines
Meet Attovia: The Clinical-Stage Biotech That Aims to Stop Chronic Itch at the Source
247wallst.com - Aug 17, 2026
Attovia Therapeutics (NASDAQ:ATTO) has arrived on public markets with a pipeline built entirely on one bet: that a biparatopic antibody platform calle
Attovia Therapeutics (NASDAQ:ATTO) Director Acquires $1,785,000.00 in Stock
defenseworld.net - Aug 17, 2026
Attovia Therapeutics, Inc. (NASDAQ: ATTO - Get Free Report) Director Colin Walsh purchased 85,000 shares of the firm's stock in a transaction dated W
Attovia Therapeutics (NASDAQ:ATTO) Major Shareholder Global Strategic Fund Venbio Purchases 382,352 Shares of Stock
defenseworld.net - Aug 11, 2026
Attovia Therapeutics, Inc. (NASDAQ: ATTO - Get Free Report) major shareholder Global Strategic Fund Venbio purchased 382,352 shares of the business's
Attovia Therapeutics (NASDAQ:ATTO) Major Shareholder Redmile Group, Llc Purchases 200,000 Shares
defenseworld.net - Aug 11, 2026
Attovia Therapeutics, Inc. (NASDAQ: ATTO - Get Free Report) major shareholder Redmile Group, Llc bought 200,000 shares of Attovia Therapeutics stock
Attovia Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
globenewswire.com - Aug 6, 2026
SAN CARLOS, Calif. , Aug.
How News Affects ATTO Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track ATTO's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked ATTO news questions
- What is the latest ATTO news headline?
- The most recent ATTO headline (Aug 17, 2026) is "Meet Attovia: The Clinical-Stage Biotech That Aims to Stop Chronic Itch at the Source". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the ATTO news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What ATTO news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual ATTO options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.